Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 04, 2025
Jabil Inc. announced the acquisition of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid...
read more
Tuesday, February 04, 2025
Ardena announced that it has successfully completed the acquisition of Catalent’s state-of-the-art drug product manufacturing facility in Somerset, New Jersey.
read more
Tuesday, February 04, 2025
HealthTech BioActives (HTBA) announced the completion of a €25 million investment project to modernize its research, development and manufacturing center in Murcia, Spain.
read more
Tuesday, February 04, 2025
Eleva and 3PBIOVIAN announced a strategic alliance to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva’s technology platform.
read more
Wednesday, February 05, 2025
TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Aldevron, a leading, global Contract Development and Manufacturing Organization (CDMO) providing high-quality plasmid DNA, RNA, and proteins for research, ...
read more
Wednesday, February 05, 2025
MedPharm announced the appointment of Bill Humphries as Chief Executive Officer. Bill's leadership will enable MedPharm to accelerate its strategic growth following its merger with Tergus Pharma which significantly bolstered MedPharm's scientific, ...
read more
Thursday, February 06, 2025
Viralgen and the CTNNB1 Foundation have partnered to manufacture an investigational gene therapy designed to treat CTNNB1 Syndrome, a rare genetic disorder that affects motor and cognitive development in children.
read more
Tuesday, February 11, 2025
Bio X Cell, a provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025.
read more
Tuesday, February 11, 2025
Frontier Scientific Solutions announced that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed. This ...
read more
Tuesday, February 11, 2025
bioMérieux announced that its BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid has obtained clearance from the U.S. Food and Drug Administration (FDA). This midplex molecular panel tests for 11 of the most common bacteria, viruses, and parasites ...
read more
Tuesday, February 11, 2025
Bind Research has launched as the UK’s first not-for-profit Focused Research Organisation (FRO), committed to transforming drug discovery by targeting disordered proteins - an approach that promises new therapeutic avenues for diseases once ...
read more
Wednesday, February 12, 2025
Alcami Corporation announced the appointment of pharmaceutical industry veteran Tori E. Arens as President of Drug Product.
read more
Wednesday, February 12, 2025
Pharma Tech Industries has hired Jack Milligan as its new Vice President of Business Development. Mr. Milligan assumed his new role in mid-January.
read more
Wednesday, February 12, 2025
ArisGlobal announced its signing of the European Union’s AI Pact agreement. The public pledge promotes responsible and ethical AI development and deployment, underpinning AI’s “bigger picture”: its benefits to society.
read more
Wednesday, February 12, 2025
Axplora announced a €50 million client investment at its Mourenx site in Southwest France, securing its position as a key player in the fight against cardiovascular and metabolic diseases.
read more